发明名称 |
LONG ACTING INSULIN FOR REDUCING CARDIOVASCULAR MORBIDITY AND MORTALITY IN PREDIABETIC PATIENTS AND PATIENTS WITH TYPE 2 DIABETES |
摘要 |
This invention relates to a method of reducing cardiovascular morbidity and mortality in a prediabetic or Type 2 Diabetes patient population. The method comprises administering an effective dosage of a long acting insulin, preferably insulin glargine, to a prediabetic or Type 2 Diabetes patient.
|
申请公布号 |
CA2512820(C) |
申请公布日期 |
2013.06.04 |
申请号 |
CA20042512820 |
申请日期 |
2004.01.14 |
申请人 |
AVENTIS PHARMACEUTICALS INC. |
发明人 |
ROSSKAMP, RALF;GERSTEIN, HERTZEL |
分类号 |
A61K38/28;A61P3/08;A61P3/10;A61P9/00;A61P9/10 |
主分类号 |
A61K38/28 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|